10x Insights
Loading account…
Companies / Health Care / Guardian Pharmacy Services, Inc.
GRDN

Guardian Pharmacy Services, Inc.

Ticker GRDNATLANTA, GAFiscal year ends DecemberBook value per share $3852.33Diluted shares 63.8K

Guardian Pharmacy Services, Inc. operates as a leading pharmacy services company providing technology-enabled pharmaceutical and clinical services to long-term care facilities across the United States. The company's website is www.guardianpharmacy.com. From the company’s description.

Fiscal year 2025 · ends 12-31Changes are against fiscal 2024The amber dot is the latest twelve months, to 2026-06-30
Sales & profitability
$1.45BFY2025
+17.9% year over year
Last 12 mo $1.46B
5.02%FY2025
+10.1 percentage points
Last 12 mo 5.84%
$48.96MFY2025
+168.9% year over year
Last 12 mo $66.52M
0.00%FY2025
Last 12 mo 26.83%
Cash & financing
$100.25MFY2025
+73.0% year over year
Last 12 mo $98.86M
$67.29MFY2025
+150.3% year over year
Last 12 mo $75.29M
—
63.3MFY2025
+2.1% year over year
Last 12 mo 63.8K

Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.

What Guardian Pharmacy Services, Inc. does

In the company’s own words

Guardian Pharmacy Services, Inc. operates as a leading pharmacy services company providing technology-enabled pharmaceutical and clinical services to long-term care facilities across the United States. The company's website is www.guardianpharmacy.com.

Guardian specializes in serving assisted living facilities, behavioral health facilities, group homes, and skilled nursing facilities by delivering comprehensive medication management solutions tailored to the complex needs of residents with multiple chronic conditions and intricate drug regimens. As of December 31, 2025, the company operated 61 pharmacies, 54 of which are full-service locations, serving approximately 205,000 residents across roughly 8,400 long-term care facilities in 38 states. More than two-thirds of annual revenue derives from assisted living facilities and behavioral health facilities, which represent the company's primary target markets.

The company's service portfolio includes compliance packaging, robotic dispensing automation, electronic medication administration record integration, pharmacist consultation services, medication therapy management, antibiotic stewardship programs, and psychotropic medication optimization. Guardian operates a proprietary centralized data warehouse supporting its Guardian Compass operational platform and GuardianShield clinical analytics suite, which deliver real-time dashboards and actionable insights to enhance pharmacy operations and resident outcomes.

Guardian's business model combines local pharmacy autonomy with centralized corporate support across technology, purchasing, revenue cycle management, regulatory compliance, and business development functions. The company maintains relationships with major pharmaceutical wholesalers including Cardinal Health, McKesson Corporation, and others, and derives approximately 71 percent of revenues from Medicare Part D reimbursement, with the remainder from Medicaid, commercial plans, and other sources. No single customer represents more than 10 percent of consolidated revenues.

The company holds approximately 13 percent market share nationally in assisted living and memory care facilities based on prescription volume data. Guardian's competitive positioning reflects its purpose-built infrastructure, clinical expertise, technology investments, and focus on higher-acuity assisted living and behavioral health markets where residents typically maintain pharmacy choice rights and require sophisticated medication coordination services.

Company details
Sector
Health Care
Industry (SIC)
Retail
Headquarters
ATLANTA, GA
Fiscal year end
December
CIK
1802255
SIC
5912

Financial performance, year by year

Fiscal 2024–2025 · USD
$-224.48M$235.85M$696.19M$1.16B$1.62B20242025Last 12 moLast 12 monthsLast 12 months

The full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.

Ownership

Who owns Guardian Pharmacy Services, Inc. — and what changed

Funds as of 2026Q2 · superinvestors as of 2026-06-30

216
funds hold it
0 of 35
superinvestors hold it
$448.95M
held by funds, at market
22.7%
of shares held by funds

Largest fund holders · Guardian Pharmacy Services, Inc.’s weight in each

VANGUARD TOTAL STOCK MARKET INDEX FUND
VTI · VANGUARD INDEX FUNDS
0.00%of fund net assets
iShares Russell 2000 ETF
IWM · iShares Trust
0.02%of fund net assets
Loomis Sayles Small Cap Growth Fund
LSSIX · LOOMIS SAYLES FUNDS II
0.87%of fund net assets
Putnam Core Equity Fund
Putnam Funds Trust
—of fund net assets
Fidelity Small Cap Growth Fund
FCPGX · Fidelity Securities Fund
—of fund net assets

Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.

Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.

Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.

Connected research

Put this business in context.

Compare this company with peers, find it in your funds and follow its financial history with your connected AI:

  • “How do Guardian Pharmacy Services, Inc. and its peers compare on margins and cash generation over ten years?”
  • “Where did five years of Guardian Pharmacy Services, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
  • “What changed in Guardian Pharmacy Services, Inc.'s last four quarterly filings that the numbers alone won't show?”
See how it works →All research tools with a subscription. Use your own AI account.